Profile data is unavailable for this security.
About the company
Stella Pharma Corp is a Japan-based company mainly engaged in the therapeutic drug research and development. It is engaged in the research and development of boron drugs for boron neutron capture therapy (BNCT). BNCT is a radiation therapy that selectively destroys cancer cells by utilizing the fission reaction of B-10, which is a stable isotope of boron, and thermal neutrons with low energy. Nucleus of B-10, which is a stable isotope of boron, absorbs low-energy low-speed neutrons and immediately splits into a helium nucleus (4He nucleus (α particle)) and a lithium nuclei (7Li nuclei). When a substance containing B-10 selectively accumulates in cancer cells and is irradiated with thermal neutrons, cancer cells are selectively destroyed. Product includes steboronin (SPM-011). A phase II clinical trial is conducted for brain tumor, head and neck cancer and recurrent malignant glioma. Phase I clinical trial is started for malignant melanoma, a type of skin cancer, and angiosarcoma.
- Revenue in JPY (TTM)269.49m
- Net income in JPY-763.75m
- Incorporated2007
- Employees46.00
- LocationStella Pharma Corp3-2-7, Koraibashi, Chuo-kuOSAKA-SHI 541-0043JapanJPN
- Phone+81 647071516
- Fax+81 647072077
- Websitehttps://stella-pharma.co.jp/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TMS Co Ltd | 0.00 | -960.04m | 8.83bn | 14.00 | -- | 2.55 | -- | -- | -25.89 | -25.89 | 0.00 | 85.77 | 0.00 | -- | -- | 0.00 | -26.14 | -- | -26.78 | -- | -- | -- | -- | -- | -- | -2,219.42 | 0.00 | -- | -- | -- | -11.51 | -- | -- | -- |
Wakamoto Pharmaceutical Co Ltd | 7.74bn | 108.96m | 8.85bn | 292.00 | 80.91 | 0.733 | 90.51 | 1.14 | 3.14 | 3.14 | 222.97 | 346.51 | 0.4971 | 2.09 | 2.57 | -- | 0.70 | -2.28 | 0.8046 | -2.64 | 46.52 | 51.00 | 1.41 | -3.97 | 3.85 | -- | 0.0083 | -- | -10.65 | -6.35 | -21.19 | -- | 4.93 | -- |
Kohjin Bio Co Ltd | 4.77bn | 384.98m | 9.03bn | 157.00 | 23.01 | 2.65 | 22.14 | 1.89 | 76.77 | 76.77 | 951.17 | 666.48 | -- | -- | -- | -- | -- | -- | -- | -- | 39.44 | -- | 8.07 | -- | 1.14 | -- | 0.4249 | -- | 0.5715 | -- | -53.61 | -- | -- | -- |
Tsubota Laboratory Inc | 673.53m | -641.32m | 9.34bn | 10.00 | -- | 6.83 | -- | 13.86 | -25.15 | -25.15 | 26.42 | 53.45 | 0.2711 | 2.04 | 37.74 | -- | -25.82 | -- | -36.41 | -- | 3.17 | -- | -95.22 | -- | 2.31 | -489.86 | 0.0788 | -- | -29.45 | -- | -811.14 | -- | -- | -- |
CanBas Co Ltd (Parent) | 0.00 | -1.09bn | 9.52bn | 12.00 | -- | 3.18 | -- | -- | -64.47 | -64.47 | 0.00 | 166.10 | 0.00 | -- | -- | 0.00 | -43.91 | -65.86 | -45.99 | -79.11 | -- | -- | -- | -1,094.10 | -- | -- | 0.00 | -- | -- | -- | -45.41 | -- | -- | -- |
Linical Co Ltd | 12.31bn | 338.27m | 9.82bn | 759.00 | 26.51 | 1.09 | 11.47 | 0.798 | 14.98 | 14.98 | 544.93 | 364.60 | 0.6837 | -- | 3.59 | -- | 1.88 | 4.01 | 3.15 | 6.33 | 30.70 | 30.99 | 2.75 | 5.48 | -- | -- | 0.2603 | 50.10 | -1.67 | 1.70 | -66.32 | -9.86 | -10.18 | 4.56 |
AnGes Inc | 249.94m | -6.35bn | 10.30bn | 145.00 | -- | 0.3616 | -- | 41.22 | -32.62 | -32.62 | 1.29 | 124.45 | 0.0077 | 0.0862 | 4.77 | 1,723,752.00 | -19.47 | -28.50 | -23.06 | -33.14 | 39.85 | 39.42 | -2,540.59 | -6,726.82 | 0.9124 | -- | 0.0139 | -- | 128.13 | -24.17 | 49.45 | -- | 12.11 | -- |
Stella Pharma Corp | 269.49m | -763.75m | 10.96bn | 46.00 | -- | 4.61 | -- | 40.67 | -24.63 | -24.63 | 8.70 | 76.12 | 0.0661 | 0.0508 | 3.98 | -- | -18.74 | -22.50 | -21.00 | -24.83 | 80.63 | -- | -283.40 | -488.65 | 5.52 | -379.39 | 0.2819 | -- | 17.65 | -- | 1.94 | -- | -5.87 | -- |
KOEI CHEMICAL COMPANY, LIMITED | 19.43bn | 299.18m | 11.26bn | 387.00 | 37.55 | 0.5149 | 4.82 | 0.5794 | 61.17 | 61.17 | 3,971.90 | 4,460.94 | 0.4957 | 1.66 | 3.80 | -- | 0.7659 | 3.15 | 0.997 | 3.94 | 27.17 | 25.24 | 1.55 | 5.85 | 0.6907 | 115.66 | 0.3207 | 43.88 | 4.44 | 1.19 | -56.72 | -20.82 | -3.29 | 10.76 |
3-D Matrix Ltd | 3.74bn | -1.06bn | 11.51bn | 108.00 | -- | 18.21 | -- | 3.08 | -14.90 | -14.90 | 54.06 | 7.74 | 0.6653 | 0.4654 | 5.19 | 34,630,130.00 | -18.91 | -57.69 | -23.28 | -77.31 | 64.04 | 40.76 | -28.43 | -205.34 | 2.33 | -- | 0.8717 | -- | 53.63 | 58.87 | -29.09 | -- | -7.69 | -- |
Medinet Co Ltd | 711.82m | -1.40bn | 11.80bn | 98.00 | -- | 2.12 | -- | 16.58 | -6.00 | -6.00 | 3.03 | 21.73 | 0.124 | 11.34 | 3.78 | 7,263,510.00 | -24.31 | -21.05 | -25.48 | -22.47 | 15.25 | 28.75 | -196.06 | -135.40 | 20.08 | -- | 0.00 | -- | 4.40 | -7.90 | -14.66 | -- | -17.67 | -- |
Nano Mrna Co Ltd | 135.51m | -780.00m | 12.18bn | 17.00 | -- | 3.56 | -- | 89.87 | -11.10 | -11.10 | 1.93 | 48.61 | 0.025 | 59.02 | 9.66 | -- | -14.37 | -24.16 | -15.59 | -25.17 | 81.88 | 84.69 | -575.61 | -600.70 | 9.17 | -- | 0.2448 | -- | -32.98 | -22.88 | 40.50 | -- | -- | -- |
RaQualia Pharma Inc | 2.18bn | -253.40m | 12.49bn | 67.00 | -- | 2.08 | -- | 5.73 | -11.72 | -11.72 | 100.79 | 277.21 | 0.247 | 2.76 | 3.03 | 32,526,720.00 | -2.87 | 2.13 | -3.18 | 2.26 | 88.70 | 88.49 | -11.63 | 5.32 | 3.53 | -- | 0.4031 | 0.00 | -34.85 | 20.62 | -144.74 | -- | 0.0967 | -- |
ReproCell Inc | 2.43bn | -31.42m | 12.53bn | 92.00 | -- | 1.50 | 165.11 | 5.16 | -0.3465 | -0.3465 | 28.34 | 93.45 | 0.2788 | 5.41 | 5.60 | -- | -0.3609 | -7.35 | -0.3932 | -8.00 | 46.19 | 39.83 | -1.29 | -27.16 | 10.54 | -- | -- | -- | -17.83 | 17.39 | 89.71 | -- | 13.27 | -- |
Ohki Healthcare Holdings Co Ltd | 334.66bn | 2.21bn | 13.50bn | 576.00 | 5.98 | 0.4699 | 7.49 | 0.0403 | 160.46 | 160.46 | 24,294.61 | 2,040.70 | 2.56 | 13.33 | 4.74 | -- | 1.63 | 1.85 | 7.07 | 8.42 | 5.14 | 6.16 | 0.6356 | 0.7178 | 0.8922 | -- | 0.1993 | 13.92 | 9.92 | 5.30 | 1.28 | 1.51 | -5.34 | 5.92 |
Holder | Shares | % Held |
---|---|---|
Nikko Asset Management Co., Ltd.as of 30 Dec 2022 | 2.84m | 9.11% |
Simplex Asset Management Co., Ltd.as of 09 May 2024 | 96.60k | 0.31% |